Vimarsana
Biggest News Aggregation in the World

Page 14 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Estimates By $0.07 EPS - Vimarsana News

Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Altimmune (NASDAQ:ALT – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($0.57) EPS for the quarter, topping the consensus estimate of ($0.64) by $0.07, MarketWatch Earnings reports. Altimmune had a negative net margin of 2,200.61% and a negative return on equity of 36.90%. During the same quarter last year, the firm […]

Braun Stacey Associates Inc. Grows Stock Position in Altimmune, Inc. (NASDAQ:ALT) - Vimarsana News

Braun Stacey Associates Inc. Grows Stock Position in Altimmune, Inc. (NASDAQ:ALT)

Braun Stacey Associates Inc. increased its holdings in Altimmune, Inc. (NASDAQ:ALT – Get Rating) by 0.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 711,818 shares of the company’s stock after buying an additional 2,890 shares during the period. Braun Stacey Associates […]

Vaccines 2.0: Next-generation COVID-19 shots will be cheaper, easier to deliver and protect against more viruses, industry leaders say - Vimarsana News

Vaccines 2.0: Next-generation COVID-19 shots will be cheaper, easier to deliver and protect against more viruses, industry leaders say

Drug companies work to improve COVID-19 vaccines to fight variants of the coronavirus and other viruses and make them easier to distribute.

Source: msn.com
Altimmune : Expands Manufacturing Agreement for Covid-19 Vaccine Candidate - Vimarsana News

Altimmune : Expands Manufacturing Agreement for Covid-19 Vaccine Candidate

Altimmune Inc. said Friday it expanded its previously announced AdCOVID manufacturing collaboration with Lonza. Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune's single-dose intranasal vaccine candidate for Covid-19, at its facility near Houston. The biopharmaceutical company said that by expanding its Lonza collaboration and commissioning its own dedicated manufacturing suite, it is building extra capacity and redundancy into its manufacturing to support potential late-stage clinical trials with AdCOVID and potential...

Altimmune, Inc. to Host Earnings Call - Vimarsana News

Altimmune, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Altimmune, Inc. (NASDAQ:ALT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 8:30 AM Eastern Time.

Source: yahoo.com